Literature DB >> 14675140

Expression of parathyroid hormone-related protein (PTHrP), osteoclast differentiation factor (ODF)/receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoclastogenesis inhibitory factor (OCIF)/osteoprotegerin (OPG) in ameloblastomas.

Hiroyuki Kumamoto1, Kiyoshi Ooya.   

Abstract

BACKGROUND: To clarify the roles of osteoclast regulatory factors in progression of odontogenic tumors, expression of parathyroid hormone-related protein (PTHrP), osteoclast differentiation factor (ODF)/receptor activator of nuclear factor-kappaB ligand (RANKL), and osteoclastogenesis inhibitory factor (OCIF)/osteoprotegerin (OPG) were analyzed in ameloblastomas as well as tooth germs.
METHODS: Tissue specimens of nine tooth germs and 36 benign and one malignant ameloblastomas were examined by reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemistry for the expression of PTHrP, ODF/RANKL, and OCIF/OPG.
RESULTS: Expression of PTHrP, ODF/RANKL, and OCIF/OPG mRNA was detected in all tooth germ and ameloblastoma samples. Immunohistochemical reactivity for PTHrP was recognized in both normal and neoplastic odontogenic epithelial cells. In ameloblastomas, PTHrP reactivity in peripheral columnar or cuboidal cells was stronger than that in central polyhedral cells, and keratinizing cells showed increased PTHrP reactivity. ODF/RANKL and OCIF/OPG were expressed predominantly in mesenchymal cells rather than in odontogenic epithelial cells in both tooth germs and ameloblastomas. Epithelial ODF/RANKL and OCIF/OPG expression was slightly lower in ameloblastomas than in tooth germs. Tumor cells in plexiform ameloblastomas showed slightly higher reactivity for PTHrP and ODF/RANKL than tumor cells in follicular ameloblastomas.
CONCLUSION: Expression of PTHrP, ODF/RANKL and OCIF/OPG in tooth germs and ameloblastomas suggests that these factors might locally regulate bone metabolism and dynamics in tooth development as well as in progression of ameloblastomas. These factors might also be involved in tumor cell differentiation and/or tumor tissue structuring in ameloblastomas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14675140     DOI: 10.1111/j.1600-0714.2004.00204.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  10 in total

1.  The role of RANK/RANKL/OPG signalling pathways in osteoclastogenesis in odontogenic keratocysts, radicular cysts, and ameloblastomas.

Authors:  Merva Soluk Tekkesin; Sevcihan Mutlu; Vakur Olgac
Journal:  Head Neck Pathol       Date:  2011-06-05

2.  Expression of survivin and X chromosome-linked inhibitor of apoptosis protein in ameloblastomas.

Authors:  Hiroyuki Kumamoto; Kiyoshi Ooya
Journal:  Virchows Arch       Date:  2004-01-09       Impact factor: 4.064

Review 3.  Sonic Hedgehog Signalling Pathway and Ameloblastoma - A Review.

Authors:  Pallavi Mishra; Abikshyeet Panda; Alokenath Bandyopadhyay; Harish Kumar; Gouse Mohiddin
Journal:  J Clin Diagn Res       Date:  2015-11-01

4.  Pediatric odontogenic tumor of the jaw - a case report.

Authors:  Keerthi Muddana; Ajay Prakash Pasupula; Shyam Prasad Reddy Dorankula; Madhusudan Rao Thokala; Jaya Nagendra Krishna Muppallai
Journal:  J Clin Diagn Res       Date:  2014-02-03

Review 5.  Molecular and genetic aspects in the etiopathogenesis of ameloblastoma: An update.

Authors:  Ravleen Nagi; Shashikant Sahu; N Rakesh
Journal:  J Oral Maxillofac Pathol       Date:  2016 Sep-Dec

6.  The regulation of bone turnover in ameloblastoma using an organotypic in vitro co-culture model.

Authors:  Tuula M Eriksson; Richard M Day; Stefano Fedele; Vehid M Salih
Journal:  J Tissue Eng       Date:  2016-09-29       Impact factor: 7.813

7.  Bioinformatics Analysis Reveals Genes Involved in the Pathogenesis of Ameloblastoma and Keratocystic Odontogenic Tumor.

Authors:  Eliane Macedo Sobrinho Santos; Hércules Otacílio Santos; Ivoneth Dos Santos Dias; Sérgio Henrique Santos; Alfredo Maurício Batista de Paula; John David Feltenberger; André Luiz Sena Guimarães; Lucyana Conceição Farias
Journal:  Int J Mol Cell Med       Date:  2016-12-06

8.  Expression of parathyroid hormone related protein (PTHRP) in ameloblastomas.

Authors:  Rafael Zeballos; Ronell Bologna-Molina; Vanesa Pereira-Prado; Mariana Villarroel-Dorrego
Journal:  J Clin Exp Dent       Date:  2018-02-01

9.  Bioengineering the ameloblastoma tumour to study its effect on bone nodule formation.

Authors:  Deniz Bakkalci; Amrita Jay; Azadeh Rezaei; Christopher A Howard; Håvard Jostein Haugen; Judith Pape; Shosei Kishida; Michiko Kishida; Gavin Jell; Timothy R Arnett; Stefano Fedele; Umber Cheema
Journal:  Sci Rep       Date:  2021-12-16       Impact factor: 4.379

10.  Molecular markers of tumor invasiveness in ameloblastoma: An update.

Authors:  Yi Zhong; Wei Guo; Li Wang; Xinming Chen
Journal:  Ann Maxillofac Surg       Date:  2011-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.